German pharmaceutical firm Schering has received European Union marketing approval for its Primovist MR liver imaging agent.
Swedish marketing approval for Primovist was granted this year and the product was successfully launched there this month, the Berlin-based firm said. Based on the Swedish approval, European marketing authorization was granted after completion of a mutual recognition procedure with Sweden as a reference member state in 25 European countries, with the exception of France and Denmark, Schering said.
The product is scheduled to be introduced to European markets, starting with Germany, in the first quarter of 2005.
By AuntMinnie.com staff writers
September 30, 2004
Related Reading
Schering submits MS-325 for EU approval, June 7, 2004
Schering gets Swedish approval for Primovist, April 5, 2004
Schering gets European OK for Zevalin for NHL, January 22, 2004
Schering starts testing optical mammo, September 12, 2003
Currency effects weigh down Schering results, August 8, 2003
Copyright © 2004 AuntMinnie.com
